Literature DB >> 1410956

Laboratory tests for pneumonia in general practice: the diagnostic values depend on the duration of illness.

H Melbye1, B Straume, J Brox.   

Abstract

The usefulness in the diagnosis of pneumonia of temperature and the laboratory tests: erythrocyte sedimentation rate (ESR), leucocyte count, and C-reactive protein (CRP) was evaluated against a radiographic reference standard in 402 adult patients with respiratory tract infection in general practice. Radiographic pneumonia was diagnosed in 20 patients. CRP and ESR were the most useful tests. CRP greater than 50 mg/l had lower sensitivity and likelihood ratio (LR), 0.50 and 4.8, respectively, compared with previous studies of selected patient populations. Among patients whose duration of illness exceeded six days the corresponding LR was 11.3, due to a higher specificity in this subgroup of patients. ESR and oral temperature were also more useful in this subgroup than in patients with a shorter duration of illness. A highly significant diagnostic contribution of adding ESR and CRP to history and physical examination, particularly when the illness had lasted one week or more, was demonstrated by logistic regression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1410956     DOI: 10.3109/02813439209014067

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  18 in total

1.  A wake up call for primary care.

Authors:  Allyson Pollock
Journal:  Br J Gen Pract       Date:  2002-11       Impact factor: 5.386

2.  Community pneumonia--more help is needed to diagnose and assess severity.

Authors:  Hasse Melbye
Journal:  Br J Gen Pract       Date:  2002-11       Impact factor: 5.386

3.  A diagnostic rule for the aetiology of lower respiratory tract infections as guidance for antimicrobial treatment.

Authors:  A Willy Graffelman; Arie Knuistingh Neven; Saskia le Cessie; Aloys C M Kroes; Machiel P Springer; Peterhans J van den Broek
Journal:  Br J Gen Pract       Date:  2004-01       Impact factor: 5.386

4.  The pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussis, and its real-time counterpart.

Authors:  M Khanna; J Fan; K Pehler-Harrington; C Waters; P Douglass; J Stallock; S Kehl; K J Henrickson
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

Review 5.  Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.

Authors:  Victor van der Meer; Arie Knuistingh Neven; Peterhans J van den Broek; Willem J J Assendelft
Journal:  BMJ       Date:  2005-06-24

6.  Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection.

Authors:  R M Hopstaken; J W Muris; J A Knottnerus; A D Kester; P E Rinkens; G J Dinant
Journal:  Br J Gen Pract       Date:  2003-05       Impact factor: 5.386

7.  The course of C-reactive protein response in untreated upper respiratory tract infection.

Authors:  Hasse Melbye; Dag Hvidsten; Arne Holm; Sveine Arne Nordbø; Jan Brox
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

8.  Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care.

Authors:  Anette Holm; Svend S Pedersen; Joergen Nexoe; Niels Obel; Lars P Nielsen; Ole Koldkjaer; Court Pedersen
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

9.  Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care.

Authors:  Anette Holm; Joergen Nexoe; Lene A Bistrup; Svend S Pedersen; Niels Obel; Lars P Nielsen; Court Pedersen
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

Review 10.  [Diagnostic procedures for patients with community acquired pneumonia].

Authors:  U Flückiger; M Battegay; G Laifer
Journal:  Internist (Berl)       Date:  2007-05       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.